Page 262 - Medicare Benefit Policy Manual
P. 262

the Criteria for Being at High-Risk for Developing Colorectal
                      Cancer (Code G0121)

                      Effective for services furnished on or after July 1, 2001, screening
                      colonoscopies (code G0121) are covered when performed under the
                      following conditions:

                          1.  On individuals not meeting the criteria for being at high
                              risk for developing colorectal cancer (refer to §280.2.3);

                          2.  At a frequency of once every 10 years (i.e., at least 119 months
                              have passed following the month in which the last covered
                              G0121 screening colonoscopy was performed); and

                          3.  If the individual would otherwise qualify to have covered a
                              G0121 screening colonoscopy based on the above (see
                              §§280.2.2.D.1 and 2) but has had a covered screening flexible
                              sigmoidoscopy (code G0104), then the individual may have a
                              covered G0121 screening colonoscopy only after at least 47
                              months have passed following the month in which the last
                              covered G0104 flexible sigmoidoscopy was performed.

                      NOTE: I f during the course of the screening colonoscopy, a lesion or
                      growth is detected which results in a biopsy or removal of the growth,
                      the appropriate diagnostic procedure classified as a colonoscopy with
                      biopsy or removal should be billed and paid rather than code G0121.

                      Effective January 1, 2023, colorectal cancer screening tests include a follow-on
                      Screening Colonoscopy Performed on Individuals Not Meeting the Criteria for Being
                      at High-Risk for Developing Colorectal Cancer after a Medicare covered non-
                      invasive stool-based colorectal cancer screening test returns a positive result. Non-
                      invasive stool-based colorectal cancer screening tests include:

                          •  Screening Guaiac-based Fecal Occult Blood Test (gFOBT) (82270)
                          •  Screening Immunoassay-based Fecal Occult Blood Test (iFOBT) (G0328)
                          •  Screening The Cologuard™ – Multi-target Stool DNA (sDNA) Test (81528)

                      The frequency limitations described for Colonoscopies Performed on Individuals Not
                      Meeting the Criteria for Being at High-Risk for Developing Colorectal Cancer in this
                      section shall not apply in the instance of a follow-on Screening Colonoscopy
                      Performed on Individuals Not Meeting the Criteria for Being at High-Risk for
                      Developing Colorectal Cancer after a Medicare covered non-invasive stool-based
                      colorectal cancer screening test returns a positive result. For complete claims
                      processing information, refer to Pub 100-04, Medicare Claims Processing Manual,
                      chapter 18, section 60.
   257   258   259   260   261   262   263   264   265   266   267